Metabolic syndrome is linked to most cancers incidence
Naoki Kimoto,Yohei Miyashita,Yutaka Yata,Takeshi Aketa,Masami Yabumoto,Yasushi Sakata,Takashi Washio,Seiji Takashima,Masafumi Kitakaze
DOI: https://doi.org/10.1007/s00380-024-02474-7
2024-10-11
Heart and Vessels
Abstract:Since many people die of either cancers or cardiovascular diseases worldwide, it is important to find the clinical pitfall that provokes cardiovascular diseases and cancer overall. Since metabolic syndrome (MetS) is largely linked to cardiovascular diseases, we have come to consider that MetS, even in its early state, may prime the occurrence of cancers overall. Indeed, the importance of MetS in causing pancreatic cancer has been proved using our large medical database. We analyzed Japanese healthcare and clinical data in 2005, who were followed up until 2020 and we examined the incidence of major cancers. At the enrollment, we examined the presence or absence of MetS judged by either Japanese criteria or NCEP/ATPIII. Of 2.7 million subjects without missing data, 102,930; 200,231; 237,420; 63,435; 76,172; and 2,422 subjects suffered lung, stomach, colon, liver and prostate cancer, respectively, and myelogenous leukemia during follow-up. MetS, defined by Japanese criteria, increased ( p < 0.005 each) the incidence of cancer with a hazard ratio (HR) of 1.03–1.47 for lung, stomach, colon, liver, prostate cancers, and myelogenous leukemia. According to Japanese criteria, cancer incidence in the pre-stage MetS group was comparable to the MetS group. The results were almost identical when we defined MetS using NCEP ATP III. Taken together, we conclude that MetS is linked to majority of cancers.
cardiac & cardiovascular systems,peripheral vascular disease